These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 31940646)

  • 1. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
    Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
    Hayama K; Fujita H; Hashimoto T; Terui T;
    J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
    Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
    Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015.
    Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
    Dermatology; 2024; 240(4):553-564. PubMed ID: 38621365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of anxiety disorder in adults with hidradenitis suppurativa.
    Cohn E; Palma G; Mastacouris N; Strunk A; Garg A
    Br J Dermatol; 2024 Aug; 191(3):351-356. PubMed ID: 38564268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
    Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
    Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
    Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
    Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis suppurativa: Epidemiology and scope of the problem.
    Jemec GB; Kimball AB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.
    Kirschner U; Kahn M; Papukchieva S; Stosio K; Keis A; Biermann MHC; Häusser-Fruh G; Sturm L; Eberl M; Friedrich B; Kurzen H
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):803-809. PubMed ID: 38769083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey.
    Yüksel M; Basım P
    J Cutan Med Surg; 2020; 24(1):55-59. PubMed ID: 31698918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.